|
Variables
|
Univariate
|
Multivariate
|
|---|
|
ORs
|
95% CIs
|
P value
|
ORs
|
95% CIs
|
P value
|
|---|
|
PT (s)
|
13.12
|
4.64–18.12
|
0.00
|
6.78
|
2.65–10.89
|
0.00
|
|
Prothrombin conc.%
|
1.54
|
0.94–3.11
|
0.18
|
–
|
–
|
–
|
|
TT (s)
|
1.92
|
0.63–3.81
|
0.142
|
–
|
–
|
–
|
|
Fbg (g/l)
|
10.37
|
4.64–18.44
|
0.00
|
3.97
|
2.17–12.34
|
0.00
|
|
APTT (s)
|
2.27
|
0.87–3.44
|
0.085
|
2.33
|
0.71–7.75
|
0.11
|
|
Protein C deficiency (%)
|
11.32
|
3.45–18.44
|
0.00
|
4.81
|
3.11–10.82
|
0.00
|
|
Protein S deficiency (%)
|
10.45
|
4.31–16.85
|
0.00
|
4.32
|
2.98–11.42
|
0.00
|
|
Antithrombin deficiency (%)
|
8.98
|
4.21–18.32
|
0.00
|
2.71
|
0.64–1.74
|
0.068
|
|
Increased lipoprotein (a) (mg/l)
|
3.88
|
3.13–8.69
|
< .0001
|
2.784
|
2.23–5.36
|
0.01
|
|
Hyperhomocysteinemia (μmol/l)
|
6.24
|
3.41–19.24
|
0.000
|
7.06
|
2.15–14.6
|
0.000
|
|
APCR
|
2.11
|
1.03–3.07
|
0.03
|
2.53
|
1.12–4.71
|
0.04
|
|
FVL mutation
|
7.76
|
3.76–17.19
|
< .0001
|
6.12
|
2.25–15.41
|
0.0003
|
- Significant difference (P value < 0.05)
- ORs odds ratios, CI confidence interval, PT prothrombin time, TT thrombin time, APTT activated partial thromboplastin time, Fbg fibrinogen, APCR activated protein C resistance, FVL mutation factor V Leiden (FVL) mutation
